Gliomas: Correlation of magnetic susceptibility artifact with histologic grade

Radiology

Volumn 202, Issue 2, 1997, Pages 511-516

  Bagley, Linda J ^a,c   Grossman, Robert I ^a   Judy, Kevin D ^a   Curtis, Mark ^a   Loevner, Laurie A ^a   Polansky, Marcia ^b   Detre, John ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Astrocytoma; Brain neoplasms, MR; Magnetic resonance (MR), artifact

Indexed keywords

ARTICLE; ARTIFACT REDUCTION; CANCER GRADING; CLINICAL ARTICLE; ELECTRON SPIN RESONANCE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0031037395     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.2.9015082     Document Type: Article

References (18)

1. Recht L, Torres CO, Smith TW, Raso V, Griffin TW. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg 1990; 72:941-945.
2. Prior R, Reifenberger G, Wechsler W. Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading, and tumour growth fraction. Virchows Arch [A] 1990; 416:491-496.
3. Hall WA, Godal A, Juell S, Fodstad O. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. J Neurosurg 1992; 76:838-844.
4. Bilzer T, Stavrou D, Dahme E, et al. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch A Pathol Anat Histopathol 1991; 418: 281-293.
5. Fischbach K, Lu Y, Tiffany-Castiglioni E, Minter A, Bowman BH, Adrian GS. Expression of chimeric human transferrin genes in vitro. J Neurosci Res 1990; 27:633-641.
6. Yokomori N, Iwasa Y, Aida K, Inoue M, Tawata M, Onaya T. Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells. Endocrinology 1991; 128:1474-1480.
7. Lui YF, Yang P, Wang WL, Liu JA. Ferritin in astrocytomas. Chin Med J 1991; 104: 326-329.
8. Laske DW, Ilercil O, Akbasak A, Youle RJ, Oldfield EH. Efficacy of direct intratumoral therapy with targeted protein toxins for solid gliomas in nude mice. J Neurosurg 1994; 80:520-526.
9. Cermak J, Balla J, Jacob HS, et al. Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy efficacy. Cancer Res 1993; 53:5308-5313.
10. Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990; 174:411-415.
11. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
12. Kielhues P, Burger P, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3:255-268.
13. Mineura K, Sasajima T, Kowada M, et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994; 73:2386-2394.
14. Kondziolka D, Bernstein M, Resch L, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 1987; 67:852-857.
15. Atlas SW, Grossman RI, Gomori JM, et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology 1987; 164:71-77.
16. Fulham MJ, Melisi JW, Nishimiya J, Dwyer AJ, DiChiro G. Neuroimaging of juvenile pilocytic astrocytomas: an enigma. Radiology 1993; 189:221-225.
17. Thompson RM, Jack CR Jr, Butts K, et al. Imaging of cerebral activation at 1.5 T: optimizing a technique for conventional hardware. Radiology 1994; 190:873-877.
18. Zigun JR, Frank JA, Barrios FA, et al. Measurement of brain activity with bolus administration of contrast agent and gradient-echo MR imaging. Radiology 1993; 186: 353-356.